Status:
COMPLETED
Cross Education for Upper Extremity Motor Function and Strength in Stroke
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Stroke
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Stroke is the leading cause of disability and mortality worldwide. The impact of stroke on the upper extremity functions is a common and important cause of long-term disability. Indeed, six months aft...
Detailed Description
After a stroke, upper extremity strength and skill deficits are predominant on the paretic side. In the chronic phase of stroke, patients with moderate to severe impairment also experience functional ...
Eligibility Criteria
Inclusion
- Chronic stroke more than 3 months of stroke onset
- History of first-ever unilateral ischemic or hemorrhagic stroke
- Upper extremity motor impairment; defined by an upper extremity score ≤42 on the Fugl Meyer upper extremity (FM-UE) assessment.
- No excessive spasticity in the affected arm (Modified Ashworth Scale ≤3)
- Having the ability to communicate and understand instructions (Mini-mental state examination ≥ 24)
- Being able to sit without needing any additional support and without leaning on a backrest
Exclusion
- Cardiovascular instability (severe, uncontrolled hypertension, coronary artery disease, etc.)
- Other neurological or musculoskeletal problems that can affect upper extremity functions
- Severe upper extremity pain defined as \>7 on the Visual Analogue Scale
- Botox injections of the upper extremity within 3 months before enrollment
Key Trial Info
Start Date :
July 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2025
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06522191
Start Date
July 29 2024
End Date
May 15 2025
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi
Istanbul, Kadikoy, Turkey (Türkiye), 34730